Eckert & Ziegler Strahlen- und Medizintechnik AG

Legal Proceedings Report • Feb 16, 2009

News Details

Ad-hoc | 16 February 2009 10:15

Eckert & Ziegler: Court Action taken by a shareholder of IBt / Request regarding the launching of a mandatory takeover bid

ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Legal Matter

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

Berlin, 16 February 2009 - Eckert & Ziegler Strahlen- und Medizintechnik AG
(ISIN DE0005659700) has been informed that a shareholder of the Belgian
company IBt, in which EZAG holds 29.89% of the shares, has introduced a
claim before the Court of Appeal of Brussels whereby it alleges that
pursuant to Belgian law Eckert & Ziegler would be required to launch a
mandatory public takeover bid for about 10 mm IBt shares at a price per IBt
share of EUR 3.47.

Eckert & Ziegler denies that it would be required to launch a mandatory
public takeover bid and will vigorously challenge the claim.

---

Information and Explaination of the Issuer to this News:

When Eckert & Ziegler in February 2008 contributed her shares of BEBIG GmbH
in exchange for shares in IBt, the parties used a reference price of 3.47
EUR per IBt share for the transaction. According to Belgian law this
reference price becomes the mandatory minimum price if a takeover offer is
submitted within 12 months. The law suit now tries to force Eckert &
Ziegler to submit such a offer before the term ends on 28 February 2009.

Basis for the suit is a transfer of an option for 5 mm beneficiary at the
end of December 2008. Eckert & Ziegler had previously acquired the option
from the founders of IBt and transferred it to an independent financial
investor in order to save option maintenance fees and in order to widen its
own investor base. The plaintiff maintains that the transfer of the option
constitutes an 'acting in concert'. The wording of the claim itself is
vague, Eckert & Ziegler does not see any substance. Also, it denies the
allegations.
16.02.2009 Financial News transmitted by DGAP

---

Language: English
Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG
Robert-Rössle-Str. 10
13125 Berlin
Deutschland
Phone: +49 (0)30 941 084-0
Fax: +49 (0)30 941 084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart;
Freiverkehr in Berlin, München, Hamburg, Düsseldorf

End of News DGAP News-Service

---